Get the Stockscreener App
6.05
5.32%
-0.34
After Hours:
6.00
-0.05
-0.83%
Overview
News
Price History
Option Chain
Financials
Why BHC Down?
Discussions
Forecast
Stock Split
Dividend History
Bausch Health Companies Inc stock is traded at $6.05, with a volume of 2.90M.
It is down -5.32% in the last 24 hours and down -15.38% over the past month.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
See More
Previous Close:
$6.39
Open:
$6.36
24h Volume:
2.90M
Relative Volume:
1.46
Market Cap:
$2.24B
Revenue:
$9.47B
Net Income/Loss:
$-178.00M
P/E Ratio:
-12.60
EPS:
-0.48
Net Cash Flow:
$1.01B
1W Performance:
-9.43%
1M Performance:
-15.38%
6M Performance:
+38.44%
1Y Performance:
-25.31%
1-Day Range:
$5.90
$6.36
1-Week Range:
$5.90
$6.69
52-Week Range:
$4.25
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
Name
Bausch Health Companies Inc
Sector
Phone
514-744-6792
Address
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Compare BHC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.05 | 2.36B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Jul-10-24 | Initiated | Raymond James | Mkt Perform |
| Sep-20-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jul-29-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-29-22 | Downgrade | Truist | Buy → Hold |
| Jul-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-13-22 | Resumed | JP Morgan | Overweight |
| Mar-24-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-17-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-22-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-17-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-24-20 | Initiated | Citigroup | Buy |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-22-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-12-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-02-19 | Initiated | Goldman | Neutral |
| Oct-25-19 | Initiated | Cowen | Outperform |
| Sep-12-19 | Initiated | Guggenheim | Buy |
| Aug-15-19 | Upgrade | TD Securities | Hold → Buy |
| Jul-19-19 | Initiated | Wolfe Research | Outperform |
| Jun-11-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-20-19 | Initiated | SunTrust | Buy |
| Jan-02-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Nov-05-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-18 | Upgrade | Piper Jaffray | Underweight → Neutral |
View All
Bausch Health Companies Inc Stock (BHC) Latest News
Price momentum metrics for Bausch Health Companies Inc. explainedJuly 2025 Reactions & High Conviction Investment Ideas - newser.com
Analyzing net buyer seller activity in Bausch Health Companies Inc.Market Performance Report & Daily Price Action Insights - newser.com
Is Bausch Health Companies Inc. (BVF) stock worth buying before Fed actionJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Weiss Ratings Reaffirms Hold (C) Rating for Bausch Health Cos (NYSE:BHC) - MarketBeat
Stocks in play: Bausch Health Companies Inc. - The Globe and Mail
Bausch Health shareholders approve amended shareholder rights plan By Investing.com - Investing.com Canada
Bausch Health shareholders approve amended shareholder rights plan - Investing.com India
Bausch Health Brief: Says Shareholders Approved Ratification, Confirmation and Adoption of Amended and Restated Shareholder Rights Plan Agreement - MarketScreener
Bausch Health Announces Results of Special Meeting of Shareholders - ACCESS Newswire
Published on: 2025-10-09 05:03:56 - newser.com
How Bausch Health Companies Inc. stock reacts to fiscal policiesWeekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
Long term hold vs stop loss in Bausch Health Companies Inc.July 2025 Summary & Real-Time Market Sentiment Reports - newser.com
Can Bausch Health Companies Inc. stock resist market sell offsRecession Risk & Safe Capital Investment Plans - newser.com
Layoff Tracker: Novo’s Cuts Leave Dozens of Manufacturing Workers Jobless - BioSpace
Bausch And Teva Blocked Cheaper IBS Drug, Retailers Say - Law360
What drives Bausch Health Companies Inc stock priceTrading Psychology Tips & Free Explosive Earning Power - earlytimes.in
Dry Eye Disease Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | AbbVie, Allergan, AFT Pharmaceuticals, Akorn, Alcon Inc., Bausch Health - Barchart.com
Bausch Health’s Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV - biomb.ca
Bausch Health Companies Inc. stock outlook for YEARDollar Strength & Capital Efficiency Focused Ideas - newser.com
Why ETFs are accumulating Bausch Health Companies Inc. (BVF) stock2025 Key Lessons & Weekly High Potential Stock Alerts - newser.com
Does Bausch Health Companies Inc. (BVF) stock trade below intrinsic valueDollar Strength & Safe Capital Growth Trade Ideas - newser.com
Published on: 2025-10-05 05:04:05 - newser.com
What AI ML Trends Might Elevate Kaya Limited’s Stock ProspectsTrend Following Strategies & High Return Trading Portfolio - earlytimes.in
What drives Bausch Health Companies Inc BVF stock priceMACD Histogram Signals & Free Stock Trading Signal Access - earlytimes.in
Published on: 2025-10-05 02:52:31 - newser.com
What candlestick patterns are forming on Bausch Health Companies Inc.2025 Momentum Check & Expert Curated Trade Ideas - newser.com
Public Employees Retirement System of Ohio Has $1.54 Million Stake in Bausch Health Cos Inc. $BHC - MarketBeat
Assessing Bausch Health (NYSE:BHC) Valuation Following Recent Share Price Decline - Sahm
How supply shortages influence Bausch Health Companies Inc. (BVF) stockJuly 2025 Selloffs & Low Drawdown Investment Strategies - newser.com
Will Bausch Health Companies Inc. stock see insider buying2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Why Bausch Health Companies Inc. stock remains on buy listsMarket Trend Review & Technical Analysis for Trade Confirmation - newser.com
Published on: 2025-10-02 22:18:26 - newser.com
Is Bausch Health Companies Inc a good long term investmentHead and Shoulders Patterns & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Published on: 2025-10-01 03:11:46 - newser.com
Bausch Health to Announce Third Quarter 2025 Results on October 29 - ACCESS Newswire
Non-Invasive Beauty Tech: Bausch Health's Solta Medical Brings 3 Leading Treatments to National Television - Stock Titan
Bausch Health Companies Inc Stock (BHC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):